Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned

EO Major, TA Yousry, DB Clifford - The Lancet Neurology, 2018 - thelancet.com
Progressive multifocal leukoencephalopathy (PML) is a rare, devastating demyelinating
disease of the CNS caused by the JC virus (JCV) that occurs in patients with compromised …

Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis

R Martin, M Sospedra, M Rosito… - European journal of …, 2016 - Wiley Online Library
Multiple sclerosis (MS) is the most common inflammatory disorder of the central nervous
system (CNS) in young adults. When MS is not treated, it leads to irreversible and severe …

Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors

X Boumaza, B Bonneau, D Roos‐Weil… - Annals of …, 2023 - Wiley Online Library
Objective Our aim was to assess the real‐world effectiveness of immune checkpoint
inhibitors for treatment of patients with progressive multifocal leukoencephalopathy (PML) …

DICAM promotes TH17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation

M Charabati, C Grasmuck, S Ghannam… - Science Translational …, 2022 - science.org
The migration of circulating leukocytes into the central nervous system (CNS) is a key driver
of multiple sclerosis (MS) pathogenesis. The monoclonal antibody natalizumab proved that …

Integrin α3 promotes TH17 cell polarization and extravasation during autoimmune neuroinflammation

E Park, WE Barclay, A Barrera, TC Liao… - Science …, 2023 - science.org
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS)
caused by CNS-infiltrating leukocytes, including TH17 cells that are critical mediators of …

The human JC polyomavirus (JCPyV): virological background and clinical implications

HH Hirsch, P Kardas, D Kranz, C Leboeuf - Apmis, 2013 - Wiley Online Library
JC polyomavirus (JCPyV) was the first of now 12 PyVs detected in humans, when in 1964,
PyV particles were revealed by electron microscopy in progressive multifocal …

Treatment of progressive multifocal leukoencephalopathy with nivolumab

O Walter, E Treiner, F Bonneville… - … England Journal of …, 2019 - Mass Medical Soc
Treatment of PML with Nivolumab A patient with severe idiopathic lymphopenia and
progressive multifocal leukoencephalopathy had T-cell exhaustion and high expression of …

Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis

TP Johnson, A Nath - Current opinion in infectious diseases, 2022 - journals.lww.com
Subtyping patients into subgroups based on biotypes has emerged as a useful approach for
studying heterogeneous diseases. Understanding biotypes of HIV-associated …

Advances in treatment of progressive multifocal leukoencephalopathy

R Bernard‐Valnet, IJ Koralnik… - Annals of …, 2021 - Wiley Online Library
Progressive multifocal encephalopathy (PML) is a severe demyelinating disease of the
central nervous system (CNS) caused by JC virus (JCV), which occurs in …

Fifty years of JC polyomavirus: a brief overview and remaining questions

AL Atkinson, WJ Atwood - Viruses, 2020 - mdpi.com
In the fifty years since the discovery of JC polyomavirus (JCPyV), the body of research
representing our collective knowledge on this virus has grown substantially. As the …